Navigation Links
Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain-Related Illness
Date:5/7/2008

National Neurotechnology Initiative Act seeks to accelerate development of

new treatments for brain and nervous system ailments

SAN FRANCISCO and WASHINGTON, May 7 /PRNewswire-USNewswire/ -- A bipartisan team of prominent members of both houses of Congress introduced today the National Neurotechnology Initiative (NNTI) Act, a bill designed to foster new discoveries and accelerate the development of new and safer treatments for the one in three Americans living with a brain-related illness, injury or disease.

Championing the NNTI, Senators Pete V. Domenici (R-NM) and Patty Murray (D-WA) and Representatives Patrick J. Kennedy (D-RI 1st) and Ileana Ros-Lehtinen (R-FL 18th) have called upon Congress to reverse the growing economic burden generated by brain-related illness, which has reached $1.3 trillion per year in the U.S. due to healthcare costs and lost income.

"The sheer numbers speak for themselves: There are 100 million Americans suffering from a brain-related illness, with an enormous economic burden that continues to grow as the population ages," said Zack Lynch, Executive Director of the Neurotechnology Industry Organization. "For a modest investment, Congress has the opportunity to streamline research efforts, accelerate the development of new treatments, promote innovation by small businesses and have a meaningful impact on the lives of those suffering from devastating diseases and injuries."

Designed to increase the speed at which discoveries reach the market, the NNTI employs targeted increases in funding to improve Federal research coordination and ease bottlenecks that inhibit the development of treatments for brain-related illnesses. The bill accomplishes these goals with less than 4 percent of the total Federal neuroscience research budget -- $200 million -- and reflects a more balanced disease-cost to research-dollars-expended ratio.

"With nearly one in three Americans suffering from some kind of ne
'/>"/>

SOURCE Neurotechnology Industry Organization
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Patients, Doctors, Pharmacists Praise Bipartisan House Resolution on Compounded Hormones Containing Estriol
2. AHCA, Alliance Praise Bipartisan Johnson, Collins Letter Urging Rejection of Bush Medicare Cuts
3. Bipartisanship Trumps Liberal Agenda in PEPFAR Reauthorization
4. Efforts to Recruit, Retain and Research Nations Social Workers Gain Bipartisan Support in Congress
5. PCMA Supports Bipartisan Legislation Calling for E-Prescribing Requirement in Medicare
6. SEIU Applauds Bipartisan Leadership of Sen. Finance Committee in Push for Greater Oversight of Private Equity Takeovers of Nursing Homes
7. Capps to Lead Bipartisan Womens Caucus Congressional Delegation to Represent United States at Women Deliver Conference in London
8. Pelosi and Reid: Congress Sends President Bush Bipartisan Childrens Health Insurance Bill
9. Bipartisan Bill Expands Health Care Access for Small Businesses
10. Pelosi: Tonights Strong Bipartisan Vote for Childrens Health Insurance a Victory for Americas Children
11. Pelosi: Todays Sweeping, Bipartisan Legislation to Improve Drug Safety is a Victory for All Americans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...y of China has issued a temporary regulation on hu...the illegal organ trade, under control // and regu... regulations regarding organ transplantation and d...dical safety in the best interest of the patients....
...lture minister Zeev Boim claimed on Sunday that th...y. // The minister, who came under strong criticis...d flu, said that Israel has taken action more quic...ame time he warned of the possibility of the deadl...
...s to appear in the May 1, 2006 issue of CANCER, a ...ty says that weight training// improves the qualit... for breast cancer. A bi-weekly exercise regimen f...cal and emotional condition of the patients. In t...
...vised National TB Control Programme (RNTCP) aims a... good quality treatment and diagnostic services to... 50 - 60 % of HIV-positive people are more prone t...h and Family Welfare Minister Anbumani Ramadoss pl...
Other Medicine News:Health News:China Issues New Legislation To Ban Human Organ Trade 2Health News:Israel Claims Eradication Of Bird Flu In Poultry 2Health News:India to Implement National Action Plan against TB-HIV 2
(Date:10/7/2008)...dy Showed Larazotide Acetate Prevented Immunologic...ents with Celiac Disease, Additional Data Indicate..., ORLANDO, Fla., Oct. 7 /- Alba Ther...inical studies this week at the American,College o...eting. Data from,study CLIN 1001-004, the first Ph...
(Date:10/7/2008)...n a clinical study of adults, VYVANSE taken once-d...ithin one week, PHILADELPHIA, Oct. 7 /PRNewswire-... the global specialty biopharmaceutical company, t...mber issue of the Journal of,Clinical Psychiatry f...ention Deficit Hyperactivity Disorder (ADHD) sympt...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientifi...rstCall/ -- Ironwood,Pharmaceuticals, Inc. (former...NYSE: FRX ) today announced the presentation of r...,s safety and efficacy in 420 patients with,irrita...ysis of the data,indicates that once- daily oral d...
(Date:10/7/2008)...ERKELEY, Calif., Oct. 7 /- Aerovance ...y data from a Phase I trial of its Aerovant,inhala...h no evidence of,local irritancy following asthma ...s 10 mg dose will be the highest of three doses in...tudy, which is scheduled to begin early,next year....
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Bio advancements Expected to Drive Burn Care Market Growth Up 24700 Million 1937 1Bio advancements Expected to Drive Burn Care Market Growth Up 24700 Million 1937 2Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co Infected With HIV 911 1Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co Infected With HIV 911 2Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co Infected With HIV 911 3Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co Infected With HIV 911 4PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation 909 1PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation 909 2PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation 909 3Attitudes toward mammography differ across ethnicities cultures backgrounds 6892 1Attitudes toward mammography differ across ethnicities cultures backgrounds 6892 2
...n Pharmaceuticals Inc.,(TSX: TLN) announced today ... trial investigating ECO-4601 in advanced cancer,p...the American,Society of Clinical Oncology (ASCO) A... dose escalation portion of the study, 14,patients...e,glioma), that had completed and not responded to...
...mpares favorably with,the activity of mTOR inhibit...rstCall/ - AEterna,Zentaris Inc. , a global biopha...nd oncology, today announced that its partner,Ker... Phase 1 and,Phase 2 results for perifosine, an or...und, for the treatment of patients with,advanced s...
Other Medicine Technology:Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 2AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 4
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: